Solana Co — Director's Dealing 2020

Oct 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2020-10-21

Reporting Person: LaViscount Joyce N (CFO and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-21	Class A Common Stock	A	38138	$0.4619	Acquired	148743	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-21	Warrant (Right to Buy)	$0.4619	A	19069	Acquired	2023-10-26	Class A Common Stock (19069)	Direct

Footnotes

F1: Immediately exercisable.